This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...

Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. What caught the Swiss pharma’s eye ...

This article was produced in partnership with Regeneron by Scientific American Custom Media, a division separate from the magazine’s board of editors. In the long-running quest to improve on ...

Lugano, 4 December 2025 – The ESMO Immuno-Oncology Congress 2025 will take place from 10–12 December in London, UK, bringing together specialists in cancer immunotherapy to present and discuss ...

LYON, France & PITTSBURGH--(BUSINESS WIRE)--Brenus Pharma, a clinical-stage biotechnology company developing first-in-class in vivo immunotherapies for solid tumors, announced the appointment of ...

Cluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, 2100 Copenhagen Ø, Denmark Department of Clinical Physiology, Nuclear Medicine & PET, ...

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the world nearly blind. A new clinical study provides a possible solution that ...

Imagine slowly losing the center of your vision, like a camera lens fading to fog. That's what happens with geographic atrophy, a severe form of age-related macular degeneration (AMD). It's the ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Learning to read again Study participant Sheila Irvine, a patient at Moorfields Eye Hospital, training with the PRIMA device. (Courtesy: Moorfields Eye Hospital) A tiny wireless implant inserted under ...